Evidence map›Paper›PMID 41346559›Full record

ArticleInternational journal of trichology

Partial Alopecia Area Retains Bulge Hair Follicle Progenitor Cells in Indian Androgenetic Alopecia Patients.

Akshay Hegde, Dyuti Saha, Savitha Somaiah, Colin Jamora

Abstract read
In one paragraph

Article in International journal of trichology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Akshay Hegde *Centre for Inflammation and Tissue Homeostasis, IFOM-inStem Joint Research Laboratory, Institute for Stem Cell Science and Regenerative Medicine, Bangalore, Karnataka, India.
Dyuti Saha *Centre for Inflammation and Tissue Homeostasis, IFOM-inStem Joint Research Laboratory, Institute for Stem Cell Science and Regenerative Medicine, Bangalore, Karnataka, India.
Savitha SomaiahSapthagiri Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India.
Colin JamoraCentre for Inflammation and Tissue Homeostasis, IFOM-inStem Joint Research Laboratory, Institute for Stem Cell Science and Regenerative Medicine, Bangalore, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Androgenic alopecia (AGA) is a pathological condition characterized by the progressive decrease of scalp hair follicle density. Completely bald areas of AGA scalp exhibit a drastically decreased number of progenitor cells. However, it is unknown when the progenitor cells begin to diminish in number during the progression of AGA. Despite the prevalence of AGA in 58% of the Indian male population, no study to date has characterized the hair follicle stem and progenitor cell populations in AGA patients in this ethnic group. Aims and Objective: In this study, we tested the presence of progenitor cells marked by CD34 and Sox9 in the partially and fully bald scalp of Indian AGA patients. Material and Methods: We utilized punch biopsies from the scalp of Indian AGA patients and quantified the status of hair follicle progenitor cells via histological and immunofluorescence analysis. Results: We observed that the partially bald area retains progenitor cells expressing CD34 and Sox9, but they are not present in the hair follicles in the completely bald area. Conclusion: Therapeutic interventions based on maintaining and activating hair follicle progenitor cells would be most effective at the partially bald stage of AGA.

Indexed as

Alopeciaalopecia treatmentandrogenetic alopeciaCD34hair folliclemedical dermatologyprogenitor cellsSox9stem cells

Identifiers

PMID41346559
PMCPMC12674495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.